C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LDLRAD3 mRNA" | 28433925 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of LDLRAD3 mRNA | 19770486 |
C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in decreased expression of LDLRAD3 mRNA | 26377693 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of LDLRAD3 mRNA | 19770486|2071347 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LDLRAD3 mRNA" | 19150397 |
D004958 | Estradiol | Estradiol results in increased expression of LDLRAD3 mRNA | 23019147 |
C006780 | bisphenol A | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LDLRAD3 mRNA" | 28433925 |
D003033 | Coal Tar | Coal Tar results in decreased expression of LDLRAD3 mRNA | 27858113 |
D002945 | Cisplatin | Cisplatin results in decreased expression of LDLRAD3 mRNA | 27594783 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of LDLRAD3 mRNA | 28433925 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of LDLRAD3 mRNA | 18042831 |
D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of LDLRAD3 mRNA | 28433925 |
D004051 | Diethylhexyl Phthalate | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LDLRAD3 mRNA" | 28433925 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LDLRAD3 mRNA | 22079256 |
C546771 | gardiquimod | gardiquimod results in increased expression of LDLRAD3 mRNA | 28003376 |
C546771 | gardiquimod | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LDLRAD3 mRNA] | 28003376 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LDLRAD3 mRNA | 25613284 |
C008261 | lead acetate | lead acetate results in increased expression of LDLRAD3 mRNA | 21829687 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA | 26378955 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of LDLRAD3 mRNA" | 25554681 |
D009538 | Nicotine | Nicotine results in increased splicing of LDLRAD3 mRNA alternative form | 23825647 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of LDLRAD3 mRNA | 24205000 |
D000073878 | Palm Oil | Palm Oil results in increased expression of LDLRAD3 mRNA | 18042831 |
D010634 | Phenobarbital | Phenobarbital affects the expression of LDLRAD3 mRNA | 23091169 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of LDLRAD3 mRNA | 26272509 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LDLRAD3 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of LDLRAD3 mRNA | 22079256 |
D047428 | Protein Kinase Inhibitors | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LDLRAD3 mRNA] | 28003376 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of LDLRAD3 mRNA | 25895662 |
D018038 | Sodium Selenite | Sodium Selenite results in increased expression of LDLRAD3 mRNA | 18175754 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA | 26378955 |
D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LDLRAD3 mRNA" | 28433925 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LDLRAD3 mRNA | 25613284 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of LDLRAD3 mRNA | 28065790 |
D014212 | Tretinoin | Tretinoin results in decreased expression of LDLRAD3 mRNA | 21934132 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
C012589 | trichostatin A | trichostatin A results in decreased expression of LDLRAD3 mRNA | 26272509 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LDLRAD3 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of LDLRAD3 mRNA | 23179753|2627250 |